Research into biomarker imaging has identified sigma-2 receptors as potential candidates for the identification of proliferative tumour sub-volumes in HNC, based on the elevated expressions of sigma receptors in proliferating cells compared to quiescent cells [40]. The gene discussed is TMEM97; the disease is neoplasm.